The University of Washington IBD Center offers comprehensive state-of-the-art care for patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.
We believe in a multi-disciplinary team approach to providing top-quality care for patients. Our expert physicians prescribe the latest treatment options, many of which are not available at other institutions, including clinical trials of promising new therapies.
Our expert physicians, surgeons, nurses and other healthcare professionals work together as an integrated team with the goal of providing the best care possible to each individual patient.
We recognize the physical and emotional challenges that come with a diagnosis of IBD and we work with each patient to develop a customized approach to effective treatment that minimizes side effects.
Our focus is to improve the health, nutrition and overall quality of life for our patients through education, support and counseling.
The term inflammatory bowel disease (IBD) encompasses a spectrum of inflammatory diseases that includes both Crohn’s disease and ulcerative colitis.
These diseases stem from an overly active immune system that attacks and damages the intestine.
Approximately 1.4 million people in North America are affected by IBD.
The cause of these diseases is not known, but both genetic and environmental factors are implicated.
Many patients with IBD have a family member who is also affected by the disease. However, the majority of patients do not have a family history of IBD.
Although the disease can have onset at any age, patients typically develop symptoms in their teenage or early adult years.
Our team of healthcare professionals draws on the expertise of multiple disciplines, including adult and pediatric gastroenterology, colorectal surgery, radiology, pathology, and nutrition.
We function as a cohesive team of specialists to provide patients with integrated and comprehensive care.